N1,N3-Bis(2,2,6,6-tetramethylpiperidin-4-yl)isophthalamide, 99+%, 1g

(R)-4-(Fluoromethyl)oxazolidin-2-one, 97%, 100mg

4-Piperidinecarboxylic acid t-butyl ester hydrochloride, 95.0%, 1g

Solution étalon ICP de zinc, 500 ml, 10 000 mg/l Zn, HDPE

4-Cyano-3-nitrobenzoic acid, 98%, 5g

4,7,13,16,21,24-Hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane, 98.0%, 10g

(2E)-1-(3-methoxyphenyl)-3-(thiophen-2-yl)prop-2-en-1-one, 95.0%, 2g

L-Phenylalanine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-, 2,5-dioxo-1-pyrrolidinyl ester, 95%, 25g

2-(3,4-DIMETHOXYPHENYL)-2-METHYLPROPANENITRILE, 97.0%, 100mg

3-Bromo-4-(difluoromethyl)pyridin-2-amine, 100mg

2,4-Dimethylbenzene-1,3-diol, 95+%, 1g

6-Methyl-2-aminobenzoxazol, 95.0%, 1g

7H-Indeno[2,1-c]quinolin-7-one, 6-[[2-(dimethylamino)ethyl]amino]-3-hydroxy-, hydrochloride (1:2), 50mg